Sunil V. Rao, MD
Department / Division
Medicine /
Medicine - Cardiology
Address
508 Fulton Street, 111A
Durham, NC 27705
Appointment Telephone
Not accepting patients
Office Telephone
919-286-0411, ext. 2352
Fax Telephone
919-286-6821
- MD, Ohio State University College of Medicine, 1996
- Internal Medicine, Duke University Medical Center, 1996-1999
- Cardiology, Duke University Medical Center, 1999-2003
- Interventional Cardiology, Duke University Medical Center, 2003-2004
Clinical Interests
Interventional cardiology
Research Interests
Focus of research is in the radial approach to PCI, transfusion physiology and outcomes in patients with ischemic heart disease, quality assessment and improvement through registries, and clinical trials in interventional cardiology
This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- AstraZeneca
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Medicines Company
- Terumo Corporation
Representative Publications
Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, Budaj A, Niemelä M, Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, Chrolavicius S, Mehta SR, . Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011 Apr 23;377(9775):1409-20.
(2011)
Abstract
Rao SV, Krucoff MW. Transradial PCI in women: problem solved or clinical equipoise? J Invasive Cardiol. 2011 Mar;23(3):4 p preceding 101.
(2011)
Abstract
Rao SV, Cohen MG, Kandzari DE, Bertrand OF, Gilchrist IC. The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. J Am Coll Cardiol. 2010 May 18;55(20):2187-95.
(2010)
Abstract
Rao SV, Melloni C, Myles-Dimauro S, Broderick S, Kosinski AS, Kleiman NS, Dzavík V, Tanguay JF, Chandna H, Gammon R, Rivera E, Alexander JH, Fier I, Roach J, Becker RC, . Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial. Circulation. 2010 Apr 20;121(15):1713-21.
(2010)
Abstract
Rao SV, Eikelboom J, Steg PG, Lincoff AM, Weintraub WS, Bassand JP, Rao AK, Gibson CM, Petersen JL, Mehran R, Manoukian SV, Charnigo R, Lee KL, Moscucci M, Harrington RA, . Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group. Am Heart J. 2009 Dec;158(6):881-886.e1.
(2009)
Abstract
Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson ED. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv. 2008 Aug;1(4):379-86.
(2008)
Abstract
Rao SV, Eikelboom JA, Granger CB, Harrington RA, Califf RM, Bassand JP. Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007 May;28(10):1193-204.
(2007)
Abstract
Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, Stamler JS, Califf RM. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA. 2004 Oct 6;292(13):1555-62.
(2004)
Abstract
